CoChat

Prognosis of Alzheimer's disease today: A two‐year prospective study in 686 patients from the REAL‐FR Study

Cortes, Frédéric, Nourhashémi, Fati, Guérin, Olivier, Cantet, Christelle, Gillette-Guyonnet, Sophie, Andrieu, Sandrine, Ousset, Pierre-Jean, Vellas, Bruno, REAL-FR Group · 2008 · Alzheimer's & Dementia
Cited by 106

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Background: The aim of the present study was to describe the long‐term evolution of Alzheimer's disease (AD) in a prospective cohort of patients under treatment with a close follow‐up. Methods: Six hundred eighty‐six AD patients from the French Network on AD (REAL‐FR) were followed up and assessed every 6 months for 2 years. Cognitive, functional, behavioral, nutritional, and global status were evaluated by using Mini‐Mental State Examination (MMSE), cognitive subscale of AD Assessment Scale (ADAS‐cog), Activities of Daily Living scale (ADL), Neuropsychiatric Inventory (NPI), Mini‐Nutritional Assessment (MNA), and Clinical Dementia Rating (CDR). Results: There were 85.13% of patients who were specifically treated for AD during their participation in the study. We observed significant changes (P < .0001) on MMSE, –4.57 ± 0.23; ADAS‐cog, 7.11 ± 0.41; ADL, –1.32 ± 0.07; NPI, 2.94 ± 0.77; MNA, –0.81 ± 0.17; and sum of boxes of the CDR (CDR‐SB), 4.17 ± 0.17. After 2 years, 10.79% (95% confidence interval [CI], 8.47 to 13.11) of the patients evolved twice as rapidly as the mean of the whole cohort on MMSE (loss, ≥9 points), 65.89% (95% CI, 62.34 to 69.44) reported a loss of 3 to 9 points, and 23.32% (95% CI, 20.16 to 26.46) were stable or improved (loss of –2 points maximum). Annual incidences for institutionalization, hospitalization, and death were 11.84% (95% CI, 9.76 to 13.92), 26.13% (95% CI, 22.52 to 29.74), and 5.95% (95% CI, 4.56 to 7.34), respectively. Conclusions: In a recent large AD cohort mostly under treatment, AD evolution appeared to be variable, with high incidences for death or institutionalization and with 11.84% of the patients exhibiting a rapid cognitive decline, whereas one fourth of the cohort appeared in relatively stable condition, and two thirds had a moderate but significant evolution of the disease. More studies are needed to better understand these variations in patients’ evolution.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jalz.2007.10.018

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 106

Metadata

Authors
Cortes, F., Nourhashémi, F., Guérin, O., Cantet, C., Gillette-Guyonnet, S., Andrieu, S., Ousset, P.-J., Vellas, B., & REAL-FR Group
Venue
Alzheimer's & Dementia
Publisher
Wiley
Published
2008-01
Volume
4
Issue
1
Pages
22-29
ISSN
  • 1552-5260 (ISSN-L)
  • 1552-5279
OpenAlex
W2167075666
Cited by
106
References
7
FWCI
4.60
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prognosis of Alzheimer's disease today: A two‐year prospective study in 686 patients from the REAL‐FR Study. https://app.cochat.ai/papers/10.1016/j.jalz.2007.10.018
The paper
Cortes, F., Nourhashémi, F., Guérin, O., Cantet, C., Gillette-Guyonnet, S., Andrieu, S., Ousset, P.-J., Vellas, B., & REAL-FR Group. (2008). Prognosis of Alzheimer's disease today: A two‐year prospective study in 686 patients from the REAL‐FR Study. Alzheimer's & Dementia. https://doi.org/10.1016/j.jalz.2007.10.018

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.